Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease. Pauwels RWM, Ten Bokkel Huinink S, van der Woude CJ, Doukas M, et al. Scand J Gastroenterol 2023 Mar 27:1-8. doi: 10.1080/00365521.2023.2194009.

Read + Share

Amedeo Smart

Independent Medical Education

Pauwels RWM, Ten Bokkel Huinink S, van der Woude CJ, Doukas M, et al. Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease. Scand J Gastroenterol 2023 Mar 27:1-8. doi: 10.1080/00365521.2023.2194009.
PMID: 36970968